Dot Compliance Briefing Note Axendia was recently briefed by the executive team at Dot Compliance, on its newly released, ready-to-use AI-powered QMS. Headquartered in Phoenix, […]
Say Hello to Dottie: Combining Quality, Compliance and Production Optimization with AI Read More »
We’ve all heard the term nanotechnology thrown around, but what does it actually mean? Nanotechnology is the use of materials that exist on the nanometer
Big Things Come in Small Packages: FDA’s Approach to Nanotechnology Read More »
Event Brief: Honeywell User Group Meeting 2023 Honeywell held its 46th global annual user group meeting (HUG) in Orlando, FL from 19-21 June 2023. The
Optimizing Transformation Read More »
Rootstock Briefing Note Axendia was recently briefed by the executive team at Rootstock, a cloud ERP solution natively built on the Salesforce Platform for companies
Are You Listening to Your Signal Chain? Read More »
Event Brief: PTC LiveWorx 2023 Axendia’s Sr. Industry Analyst, Sandra K. Rodriguez, was invited to attend and cover PTC’s LiveWorx 2023 at the Boston Convention
The Future Is Not Something We Enter. The Future is Something We Create. Read More »
FDA’s Center for Drug Evaluation and Research (CDER) recently released its fifth annual report on the State of Pharmaceutical Quality. It reviews the state of
FDA Reports on the State of Pharmaceutical Quality Read More »
Webinar Available On-Demand Axendia’s Sr. Industry Analyst, Sandra K. Rodriguez, was joined by Leigh Young, PLM Product Manager at Aras Corporation to discuss how industry
Harnessing the Power of PLM Read More »
The Inflation Reduction Act (IRA) will drive a significant change in the pharmaceutical industry, empowering Medicare to negotiate the prices of high-cost single-source brand-name drugs
Price Negotiations: 10 Initiatives Pharma Must Consider To Mitigate Impacts Read More »
“The regulatory uses of AI are real: In 2021, more than 100 drug and biologic applications submitted to the FDA included AI/ML components. These submissions
Artificial Intelligence has the Attention of Regulators Read More »
Event Brief: ComplianceQuest Inaugural User Conference Axendia’s Sr. Industry Analyst, Sandra K. Rodriguez, was invited to attend the Inaugural ComplianceQuest User Conference, ConQuest, at the
ConQuest 2023: Innovations to Drive Collaboration and Empowerment Read More »
An Axendia Market Readiness Assessment Report While most biopharma companies have complex stage-gate product development, change management and investigation processes, they lack the ability to
Accelerating Time To Market with Biopharma PLM Read More »
Scitara Briefing Note Axendia was recently briefed by Jeffrey Mazzeo, Ph.D., chief marketing officer at Scitara Corporation. The company was started three years ago with
No Instrument Left Behind Read More »
